Capital World Investors Novo Nordisk A S Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital World Investors holds 3,928,422 shares of NVO stock, worth $531 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,928,422

Previous 3,971,417 1.08%

Holding current value

$531 Million

Previous $411 Million 22.77%

% of portfolio

0.09%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $4.39 Million - $5.84 Million	-42,995 Reduced 1.08%	3,928,422 $504 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $444,079 - $533,471	5,059 Added 0.13%	3,971,417 $411 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $180 Million - $396 Million	1,984,357 Added 100.12%	3,966,358 $361 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $35.7 Million - $39.6 Million	229,144 Added 13.07%	1,982,001 $321 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $46.8 Million - $56.3 Million	353,770 Added 25.29%	1,752,857 $279 Million

Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $68.7 Million - $90.7 Million	669,955 Added 91.88%	1,399,087 $189 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $66 Million - $81 Million	692,521 Added 1891.57%	729,132 $72.7 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $67,106 - $79,176	650 Added 1.81%	36,611 $4.03 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $208,450 - $251,977	2,239 Added 6.64%	35,961 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $269,998 - $329,697	2,816 Added 9.11%	33,722 $3.76 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $71,334 - $90,093	845 Added 2.81%	30,906 $2.97 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $152,911 - $191,557	2,260 Added 8.13%	30,061 $2.52 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $308,073 - $348,317	4,594 Added 19.8%	27,801 $1.89 Million
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $206,428 - $238,447	3,231 Added 16.17%	23,207 $1.63 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $71,269 - $78,576	1,119 Added 5.93%	19,976 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $360,313 - $418,170	6,155 Added 48.46%	18,857 $1.24 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $194,377 - $254,585	3,930 Added 44.8%	12,702 $764,000
Q4 2019 Feb 18, 2020	BUY	$49.86 - $58.26 $97,476 - $113,898	1,955 Added 28.68%	8,772 $506,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $312,765 - $351,515	6,579 Added 2764.29%	6,817 $352,000
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $10,621 - $11,910	227 Added 2063.64%	238 $12,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $514 - $563	11 New	11 $1,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $265 - $302	-6 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $290 - $348	6 New	6 $0
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $237 - $268	-5 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $205 - $246	5	5 $0

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Novo Nordisk A S Transaction History